Equillium, Inc. (EQ) shareholders
Close on Nov 16, 2026Market cap $72.92MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC Joint filing with Daniel Schneeberger (9.90%), ADAR1 Capital Management GP, LLC (9.50%) | 6,603,754 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| RA Capital Healthcare Fund, L.P. Joint filing with RA Capital Management, L.P. (9.90%), Peter Kolchinsky (9.90%) and 1 more | 6,480,209 | 9.90% | 13G (passive) | Mar 13, 2026 |
| ADAR1 Capital Management GP, LLC Joint filing with ADAR1 Capital Management, LLC (9.90%), Daniel Schneeberger (9.90%) | 6,194,882 | 9.90% | 13G (passive) | Sep 30, 2025 |
| Janus Henderson Group PLC | 6,083,239 | 9.99% | 13G (passive) amendment | Jan 30, 2026 |
| Phillip Gross Joint filing with Adage Capital Management, L.P. (9.99%), Robert Atchinson (9.99%) | 6,012,624 | 9.99% | 13G (passive) | Sep 30, 2025 |
| Xiangmin Cui Joint filing with Decheng Capital Management IV (Cayman), LLC (6.70%), Decheng Capital Global Life Sciences Fund IV, L.P. (6.70%) | 5,733,021 | 8.90% | 13G (passive) amendment | Mar 31, 2026 |
| Robert Atchinson Joint filing with Adage Capital Management, L.P. (7.25%), Phillip Gross (7.25%) | 4,832,767 | 7.25% | 13G (passive) amendment | Jun 30, 2026 |
| abrdn Inc. Joint filing with Aberdeen Group plc (7.03%) | 4,458,351 | 7.03% | 13G (passive) amendment | Sep 30, 2026 |
| Affinity Asset Advisors, LLC Joint filing with Michael Cho (6.50%) | 4,100,000 | 6.50% | 13G (passive) | Jun 30, 2026 |
| Woodline Partners LP | 3,508,771 | 5.90% | 13G (passive) | Sep 30, 2025 |
| Takeda Pharmaceutical Company Limited Joint filing with Takeda Ventures, Inc. (5.20%) | 1,842,977 | 5.20% | 13G (passive) | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EQ | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 6,494,571 | 10.24% | $20.69M | New | 0.01% |
| Decheng Capital LLC | 4,447,308 | 7.01% | $14.23M | – | 1.94% |
| Affinity Asset Advisors, LLC | 4,100,000 | 6.47% | $13.12M | +2,873,690 | 0.59% |
| ADAR1 Capital Management, LLC | 3,758,569 | 5.93% | $12.03M | +31,910 | 0.55% |
| abrdn plc | 3,631,659 | 5.73% | $11.62M | +278,822 | 0.02% |
| Woodline Partners LP | 3,500,901 | 5.52% | $11.20M | – | 0.03% |
| Ra Capital Management, L.P. | 3,096,336 | 4.88% | $9.91M | – | 0.09% |
| Stempoint Capital LP | 2,016,607 | 3.18% | $6.45M | New | 1.11% |
| Vanguard Capital Management LLC | 1,822,812 | 2.87% | $5.83M | +38,340 | 0.00% |
| Eversept Partners, LP | 1,520,824 | 2.40% | $4.87M | +21,831 | 0.25% |
| Adage Capital Partners Gp, L.L.C. | 1,390,253 | 2.19% | $4.45M | −3,939,163 | 0.01% |
| Renaissance Technologies LLC | 637,617 | 1.01% | $2.04M | −19,347 | 0.00% |
| Exome Asset Management LLC | 552,956 | 0.87% | $1.77M | New | 1.09% |
| DG Capital Management, LLC | 463,396 | 0.73% | $1.48M | New | 0.31% |
| Diadema Partners LP | 400,282 | 0.63% | $1.28M | −33,562 | 0.16% |
| Geode Capital Management, LLC | 381,175 | 0.60% | $1.22M | +2,362 | 0.00% |
| Balyasny Asset Management L.P. | 344,409 | 0.54% | $1.10M | −1,294,361 | 0.00% |
| Tudor Investment Corp Et Al | 320,100 | 0.50% | $1.02M | +300,000 | 0.00% |
| Ikarian Capital, LLC | 303,555 | 0.48% | $971.38K | – | 0.10% |
| BlackRock, Inc. | 285,409 | 0.45% | $913.31K | +157,557 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 60 | 42M | 65.8% | 19 / 17 | 14 / 8 | 14M | 6M |
| Q1 2026 | 50 | 40M | 63.9% | 19 / 9 | 11 / 4 | 10M | 3M |
| Q4 2025 | 36 | 35M | 55.7% | 8 / 15 | 7 / 11 | 10M | 2M |
| Q3 2025 | 40 | 30M | 46.8% | 21 / 7 | 6 / 8 | 22M | 1M |
| Q2 2025 | 27 | 9M | 13.7% | 6 / 6 | 6 / 2 | 0M | 0M |
| Q1 2025 | 24 | 9M | 13.7% | 2 / 6 | 6 / 4 | 0M | 0M |
| Q4 2024 | 26 | 9M | 13.7% | 6 / 3 | 6 / 6 | 0M | 0M |
| Q3 2024 | 26 | 9M | 13.7% | 7 / 3 | 5 / 5 | 0M | 0M |
| Q2 2024 | 25 | 9M | 14.2% | 5 / 6 | 4 / 8 | 0M | 0M |
| Q1 2024 | 28 | 9M | 14.3% | 8 / 6 | 10 / 5 | 1M | 1M |
| Q4 2023 | 25 | 10M | 15.5% | 6 / 4 | 6 / 5 | 6M | 1M |
| Q3 2023 | 25 | 9M | 14.4% | 1 / 6 | 6 / 3 | 0M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
14 funds held EQ in Q2 2026, 82% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of EQ | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,401,958 | 2.21% | $4.49M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 344,489 | 0.54% | $1.10M | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 164,610 | 0.26% | $477.37K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 147,697 | 0.23% | $472.63K | 0.03% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 54,720 | 0.09% | $158.69K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 47,465 | 0.07% | $137.65K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 36,683 | 0.06% | $106.38K | 0.00% | May 31, 2026 |
| Tiff Multi-Asset Fund | 31,335 | 0.05% | $100.27K | 0.01% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 24,987 | 0.04% | $79.96K | 0.00% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 22,500 | 0.04% | $72.00K | 0.00% | Jun 30, 2026 |
| Avantis U.S. Small Cap Equity ETF | 10,623 | 0.02% | $30.81K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 9,860 | 0.02% | $31.55K | 0.01% | Jun 30, 2026 |
| U.S. Micro Cap Portfolio | 7,668 | 0.01% | $16.87K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Small Cap ETF | 7,665 | 0.01% | $16.86K | 0.00% | Jul 31, 2026 |
| Victory Extended Market Index Fund | 5,565 | 0.01% | $12.24K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Daniel Bradbury | CHAIRMAN, Director | 3,711,995 | 5.85% | May 29, 2026 |
| Bruce D. Steel | Chief Executive Officer, Director, 10% owner | 3,711,995 | 5.85% | Jan 9, 2026 |
| Stephen Connelly | President and CSO | 762,025 | 1.20% | Jun 5, 2026 |
| Christine Zedelmayer | Sr. Vice President and COO | 62,586 | 0.10% | Jun 5, 2026 |
| Penny Tom | Principal Accounting Officer | 65,000 | 0.10% | May 29, 2026 |
| Jason A. Keyes | Chief Financial Officer | 126,633 | 0.20% | Feb 19, 2025 |
| Martha J. Demski | Director | 23,799 | 0.04% | May 29, 2026 |
| Mark Pruzanski | Director | 23,799 | 0.04% | May 29, 2026 |
| Charles Douglas McDermott | Director | 23,799 | 0.04% | May 29, 2026 |
| Barbara Troupin | Director | – | – | May 29, 2026 |
| Bala S. Manian | Director | 23,799 | 0.04% | May 23, 2025 |
| Peter Colabuono | Director | – | – | May 23, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Christine Zedelmayer Sr. Vice President and COO | Jun 5, 2026 | Sale(10b5-1 plan) | −14,584 | $2.93 | $42.73K | 62,586 |
| Christine Zedelmayer Sr. Vice President and COO | Jun 5, 2026 | Option exercise | +14,584 | $0.79 | $11.52K | 77,170 |
| Stephen Connelly President and CSO | Jun 5, 2026 | Sale | −30,975 | $2.94 | $91.07K | 762,025 |
| Stephen Connelly President and CSO | Jun 4, 2026 | Sale | −200,000 | $3.16 | $632.00K | 793,000 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Option exercise | +48,512 | $0.77 | $37.35K | 118,390 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Sale(10b5-1 plan) | −30,208 | $2.98 | $90.02K | 62,586 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Sale(10b5-1 plan) | −55,604 | $2.70 | $150.13K | 62,786 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Option exercise | +7,292 | $0.73 | $5.32K | 69,878 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Sale(10b5-1 plan) | −200 | $2.71 | $542 | 62,586 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Option exercise | +14,583 | $0.79 | $11.52K | 77,169 |
| Christine Zedelmayer Sr. Vice President and COO | May 28, 2026 | Option exercise | +15,625 | $0.79 | $12.34K | 92,794 |
| Penny Tom Principal Accounting Officer | May 28, 2026 | Option exercise | +65,000 | $0.79 | $51.35K | 65,000 |
| Penny Tom Principal Accounting Officer | May 28, 2026 | Sale(10b5-1 plan) | −65,000 | $2.95 | $191.75K | 0 |
| Christine Zedelmayer Sr. Vice President and COO | May 27, 2026 | Sale(10b5-1 plan) | −9,821 | $2.70 | $26.52K | 62,586 |
| Christine Zedelmayer Sr. Vice President and COO | May 27, 2026 | Option exercise | +9,821 | $0.77 | $7.56K | 72,407 |
| Christine Zedelmayer Sr. Vice President and COO | Mar 13, 2026 | Option exercise | +120,312 | $0.79 | $95.05K | 182,898 |
| Christine Zedelmayer Sr. Vice President and COO | Mar 13, 2026 | Sale(10b5-1 plan) | −120,312 | $2.50 | $300.78K | 62,586 |
| Christine Zedelmayer Sr. Vice President and COO | Mar 9, 2026 | Option exercise | +75,000 | $0.79 | $59.25K | 243,805 |
| Christine Zedelmayer Sr. Vice President and COO | Mar 9, 2026 | Option exercise | +41,666 | $0.79 | $32.92K | 168,805 |
| Christine Zedelmayer Sr. Vice President and COO | Mar 9, 2026 | Option exercise | +35,695 | $0.79 | $28.20K | 127,139 |
| Christine Zedelmayer Sr. Vice President and COO | Mar 9, 2026 | Sale(10b5-1 plan) | −181,219 | $2.00 | $362.44K | 62,586 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Sale(10b5-1 plan) | −109,375 | $1.78 | $194.69K | 91,444 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Option exercise | +76,562 | $0.73 | $55.89K | 168,006 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Sale(10b5-1 plan) | −76,562 | $1.74 | $133.22K | 91,444 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Option exercise | +109,375 | $0.79 | $86.41K | 200,819 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Option exercise | +76,562 | $0.73 | $55.89K | 268,006 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Sale(10b5-1 plan) | −109,375 | $1.78 | $194.69K | 191,444 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Sale(10b5-1 plan) | −76,562 | $1.74 | $133.22K | 191,444 |
| Christine Zedelmayer Sr. Vice President and COO | Feb 19, 2026 | Option exercise | +109,375 | $0.79 | $86.41K | 300,819 |
| Penny Tom Principal Accounting Officer | Jan 8, 2026 | Sale(10b5-1 plan) | −6,533 | $1.29 | $8.43K | 0 |
| Christine Zedelmayer Sr. Vice President and COO | Dec 23, 2025 | Sale(10b5-1 plan) | −100,000 | $1.50 | $150.00K | 91,444 |
| Christine Zedelmayer Sr. Vice President and COO | Dec 23, 2025 | Option exercise | +100,000 | $0.79 | $79.00K | 191,444 |
| Christine Zedelmayer Sr. Vice President and COO | Dec 15, 2025 | Sale(10b5-1 plan) | −11,900 | $1.31 | $15.59K | 91,444 |
| Christine Zedelmayer Sr. Vice President and COO | Dec 12, 2025 | Sale(10b5-1 plan) | −23,804 | $1.34 | $31.90K | 103,344 |
| Christine Zedelmayer Sr. Vice President and COO | Nov 25, 2025 | Sale(10b5-1 plan) | −100 | $0.98 | $98 | 135,146 |
| Christine Zedelmayer Sr. Vice President and COO | Nov 25, 2025 | Sale(10b5-1 plan) | −7,998 | $0.95 | $7.60K | 127,148 |
| Jason A. Keyes Chief Financial Officer | Jan 23, 2025 | Sale(10b5-1 plan) | −10,000 | $0.65 | $6.50K | 37,720 |
| Jason A. Keyes Chief Financial Officer | Dec 10, 2024 | Award | +15,000 | $0.54 | $8.10K | 88,913 |
| Jason A. Keyes Chief Financial Officer | Nov 14, 2024 | Sale(10b5-1 plan) | −10,000 | $0.70 | $7.00K | 47,720 |
| Christine Zedelmayer Sr. Vice President and COO | Oct 28, 2024 | Sale(10b5-1 plan) | −15,000 | $1.25 | $18.75K | 135,246 |
| Penny Tom Principal Accounting Officer | Oct 28, 2024 | Sale(10b5-1 plan) | −2,835 | $1.25 | $3.54K | 6,533 |
| Penny Tom Principal Accounting Officer | Oct 25, 2024 | Sale(10b5-1 plan) | −683 | $1.25 | $854 | 9,368 |
| Jason A. Keyes Chief Financial Officer | Sep 26, 2024 | Sale(10b5-1 plan) | −10,000 | $0.81 | $8.10K | 57,720 |
| Penny Tom Principal Accounting Officer | Sep 16, 2024 | Sale(10b5-1 plan) | −38,806 | $0.85 | $32.99K | 10,051 |
| Jason A. Keyes Chief Financial Officer | Jul 16, 2024 | Sale(10b5-1 plan) | −10,000 | $0.87 | $8.70K | 67,720 |
| Joel Rothman Chief Development Officer | Dec 8, 2023 | Award | +8,804 | $0.58 | $5.11K | 58,150 |
| Jason A. Keyes Chief Financial Officer | Dec 8, 2023 | Award | +8,805 | $0.58 | $5.11K | 58,913 |
| Christine Zedelmayer Sr. Vice President and COO | Dec 8, 2023 | Award | +8,804 | $0.58 | $5.11K | 135,246 |
| Joel Rothman Chief Development Officer | Jun 9, 2023 | Award | +15,000 | $0.56 | $8.40K | 49,346 |
| Jason A. Keyes Chief Financial Officer | Jun 9, 2023 | Award | +15,000 | $0.56 | $8.40K | 50,108 |
| Christine Zedelmayer Sr. Vice President and COO | Jun 9, 2023 | Award | +15,000 | $0.56 | $8.40K | 126,442 |
| Jason A. Keyes Chief Financial Officer | Dec 9, 2022 | Award | +4,444 | $1.19 | $5.29K | 35,108 |
| Joel Rothman Chief Development Officer | Dec 9, 2022 | Award | +3,821 | $1.19 | $4.55K | 34,346 |
| Jason A. Keyes Chief Financial Officer | Aug 29, 2022 | Sale(10b5-1 plan) | −7,000 | $2.83 | $19.81K | 77,720 |
| Christine Zedelmayer Sr. Vice President and COO | Jun 10, 2022 | Award | +9,033 | $1.85 | $16.71K | 111,442 |
| Joel Rothman Chief Development Officer | Jun 10, 2022 | Award | +6,244 | $1.85 | $11.55K | 30,525 |
| Jason A. Keyes Chief Financial Officer | Jun 6, 2022 | Sale(10b5-1 plan) | −5,000 | $2.52 | $12.60K | 84,720 |
| Jason A. Keyes Chief Financial Officer | Apr 4, 2022 | Sale(10b5-1 plan) | −8,000 | $3.18 | $25.44K | 89,720 |
| Jason A. Keyes Chief Financial Officer | Dec 10, 2021 | Award | +5,585 | $2.35 | $13.12K | 23,296 |
| Joel Rothman Chief Development Officer | Dec 10, 2021 | Award | +1,290 | $2.35 | $3.03K | 24,281 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Equillium's stock actually held short. Settlement fails (shares not delivered on time) peaked at 49,654 shares on Oct 6, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Stephen Connelly Officer, President and CSO | Jun 5, 2026 | 30,975 | $91.07K | Jun 5, 2026 | Founders shares acquired at incorporation |
| Stephen Connelly Officer, President and CSO | Jun 4, 2026 | 200,000 | $632.76K | Jun 4, 2026 | Founders shares acquired at incorporation |
| Christine Zedelmayer Officer | May 27, 2026 | 65,625 | $172.59K | May 27, 2026 | Stock Options |
| Christine Zedelmayer Officer | Mar 13, 2026 | 120,312 | $288.75K | Mar 13, 2026 | Stock Options |
| Christine Zedelmayer Officer | Mar 9, 2026 | 181,219 | $320.76K | Mar 9, 2026 | Stock Options |
| Christine Zedelmayer Officer | Feb 19, 2026 | 185,937 | $316.09K | Feb 19, 2026 | Stock Options |
| Penny Tom Officer | Jan 8, 2026 | 6,533 | $8.43K | Jan 8, 2026 | Employee Stock Purchase Plan Shares |
| Christine Zedelmayer Officer | Dec 23, 2025 | 100,000 | $150.00K | Dec 23, 2025 | Stock Options |
| Christine Zedelmayer Officer | Dec 12, 2025 | 23,804 | $31.90K | Dec 12, 2025 | Employee Stock Purchase Plan |
| Christine Zedelmayer Officer | Nov 25, 2025 | 8,098 | $7.43K | Nov 25, 2025 | Restricted Stock |
| Jason A. Keyes Former CFO | Jul 8, 2025 | 88,913 | $28.45K | Jul 7, 2025 | Employee Stock Purchase Plan |
| The Keyes Trust U/A Dtd 09/10/2004 Director | Jun 12, 2025 | 10,000 | $3.86K | Jun 12, 2025 | Previously Exercised Options |
| The Keyes Trust U/A Dtd 09/10/2004 Officer | Nov 14, 2024 | 20,000 | $15.61K | Nov 14, 2024 | Previously Exercised Options |
| Christine Zedelmayer Officer | Oct 31, 2024 | 15,000 | $18.75K | Oct 28, 2024 | Grant |
| The Keyes Trust U/A Dtd 09/10/2004 Officer | Jul 16, 2024 | 20,000 | $17.80K | Jul 16, 2024 | Previously Exercised Options |
See a number that looks wrong?